HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

María Jesús Oset-Gasque Selected Research

nitrones

3/2022Nucleobase-Derived Nitrones: Synthesis and Antioxidant and Neuroprotective Activities in an In Vitro Model of Ischemia-Reperfusion.
2/2021Synthesis, Neuroprotection, and Antioxidant Activity of 1,1'-Biphenylnitrones as α-Phenyl-N-tert-butylnitrone Analogues in In Vitro Ischemia Models.
1/2021Use of Radical Oxygen Species Scavenger Nitrones to Treat Oxidative Stress-Mediated Hearing Loss: State of the Art and Challenges.
1/2020Synthesis, antioxidant properties and neuroprotection of α-phenyl-tert-butylnitrone derived HomoBisNitrones in in vitro and in vivo ischemia models.
5/2019Synthesis and Neuroprotective Properties of N-Substituted C-Dialkoxyphosphorylated Nitrones.
1/2012Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


María Jesús Oset-Gasque Research Topics

Disease

8Alzheimer Disease (Alzheimer's Disease)
01/2020 - 08/2012
5Ischemia
03/2022 - 06/2010
5Neuroblastoma
03/2022 - 08/2016
3Brain Ischemia (Cerebral Ischemia)
03/2022 - 11/2012
3Inflammation (Inflammations)
01/2020 - 11/2012
2Stroke (Strokes)
01/2020 - 01/2012
2Necrosis
05/2019 - 02/2014
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022
1Hearing Loss (Hearing Impairment)
01/2021
1Amyloid Plaque
01/2020
1Infarction (Infarctions)
01/2020
1Hypoxia (Hypoxemia)
02/2014
1Ischemic Stroke
11/2012

Drug/Important Bio-Agent (IBA)

7AntioxidantsIBA
03/2022 - 01/2012
6nitronesIBA
03/2022 - 01/2012
5Biological ProductsIBA
01/2020 - 08/2012
4Neuroprotective AgentsIBA
06/2020 - 01/2015
4Tacrine (Cognex)FDA Link
01/2020 - 08/2012
3Superoxides (Superoxide)IBA
03/2022 - 01/2020
3Glucose (Dextrose)FDA LinkGeneric
03/2022 - 01/2020
3Oxygen (Dioxygen)IBA
03/2022 - 01/2020
3oligomycin AIBA
02/2021 - 10/2016
3RotenoneIBA
02/2021 - 10/2016
2Hydroxyl RadicalIBA
03/2022 - 01/2020
2phenyl-N-tert-butylnitroneIBA
02/2021 - 01/2020
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2020 - 11/2012
2quinolineIBA
08/2016 - 01/2012
2AcetylcholinesteraseIBA
01/2015 - 06/2013
2CytokinesIBA
01/2015 - 11/2012
1Lipoxygenase (Lipoxygenase-1)IBA
03/2022
1pyrimidineIBA
03/2022
1purineIBA
03/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1Phytoestrogens (Phytoestrogen)IBA
06/2020
1Pharmaceutical PreparationsIBA
01/2020
1tau Proteins (tau Protein)IBA
01/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1LigandsIBA
01/2018
1HydroquinonesIBA
10/2016
1prenylIBA
10/2016
1Okadaic AcidIBA
10/2016
1avarol-3'-thiosalicylateIBA
10/2016
1avarolIBA
10/2016
1Amyloid beta-PeptidesIBA
08/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2015
1ErythropoietinFDA Link
01/2015
1ChemokinesIBA
01/2015
1ButyrylcholinesteraseIBA
06/2013
1Adenosine Triphosphate (ATP)IBA
11/2012
1AminesIBA
08/2012
1Vesicular Glutamate Transport ProteinsIBA
06/2010
1Glutamic Acid (Glutamate)FDA Link
06/2010

Therapy/Procedure

5Therapeutics
01/2020 - 02/2014